# IFNA6

## Overview
IFNA6 is a gene that encodes the protein interferon alpha 6, a member of the type I interferon family, which plays a pivotal role in the immune response. The protein is categorized as a cytokine, involved in the activation of immune cells and the upregulation of antiviral proteins, thereby enhancing the body's defense mechanisms against viral infections. Interferon alpha 6 is primarily active in the cytoplasm and nucleus, where it influences gene expression through pathways such as the JAK-STAT signaling pathway, leading to the induction of interferon-stimulated genes (ISGs) (Karakoese2024IFNα). The gene has been subject to strong purifying selection, underscoring its essential role in immunity (Manry2011Evolutionary). Variations in IFNA6 have been linked to various clinical conditions, including autoimmune diseases and cancer, highlighting its significance in both health and disease contexts (Beyer2017Rare; Chan2006Variation).

## Function
IFNA6, a member of the type I interferon family, plays a critical role in the immune response by activating immune cells and upregulating antiviral proteins. It is primarily active in the cytoplasm and nucleus, where it influences gene expression to enhance antiviral defense mechanisms (Karakoese2024IFNα). IFNA6 is involved in the activation of the JAK-STAT signaling pathway, which leads to the formation of the ISGF3 complex. This complex translocates to the nucleus to induce the transcription of interferon-stimulated genes (ISGs), contributing to the establishment of an antiviral state in cells (Karakoese2024IFNα).

The gene has been subject to strong purifying selection, indicating its essential and nonredundant role in immunity to infection (Manry2011Evolutionary). IFNA6, along with other type I IFNs, shows low levels of amino acid-altering variation, suggesting that it is under evolutionary pressure to maintain its sequence integrity due to its crucial functions (Manry2011Evolutionary). The protein's role in immune function is further supported by its ability to significantly increase the expression of ISGs, which are known to have roles in antiviral defense (Li2017Expression).

## Clinical Significance
The IFNA6 gene, part of the type I interferon family, has been implicated in various clinical conditions due to its altered expression. In glioma and prostate carcinoma, increased expression of IFNA6 has been observed in patients with rare ADAR or RNASEH2B variants. This overexpression is associated with a type I interferon signature, which may contribute to tumorigenesis by enhancing immune cell recruitment and promoting an inflammatory environment within tumors (Beyer2017Rare). 

In autoimmune diseases such as systemic lupus erythematosus (SLE), IFNA6 is part of a delayed induction group of IFN-inducible genes, which are consistently highly expressed in patients. This expression pattern is linked to the pathogenesis of SLE, as it correlates with increased IFN-α activity and downstream effects on immune cell activation (Feng2013Bioinformatics). 

Additionally, variations in the IFNA6 gene have been associated with atopic phenotypes, such as positive skin prick tests to mold and cockroach allergens, suggesting a role in allergic responses (Chan2006Variation). These findings highlight the clinical significance of IFNA6 in both cancer and autoimmune conditions.


## References


[1. (Li2017Expression) Yanpeng Li, Binlian Sun, Stefan Esser, Heiko Jessen, Hendrik Streeck, Marek Widera, Rongge Yang, Ulf Dittmer, and Kathrin Sutter. Expression pattern of individual ifna subtypes in chronic hiv infection. Journal of Interferon &amp; Cytokine Research, 37(12):541–549, December 2017. URL: http://dx.doi.org/10.1089/jir.2017.0076, doi:10.1089/jir.2017.0076. This article has 19 citations.](https://doi.org/10.1089/jir.2017.0076)

[2. (Beyer2017Rare) Ulrike Beyer, Frank Brand, Helge Martens, Julia Weder, Arne Christians, Natalie Elyan, Bettina Hentschel, Manfred Westphal, Gabriele Schackert, Torsten Pietsch, Bujung Hong, Joachim K. Krauss, Amir Samii, Peter Raab, Anibh Das, Claudia A. Dumitru, I. Erol Sandalcioglu, Oliver W. Hakenberg, Andreas Erbersdobler, Ulrich Lehmann, Guido Reifenberger, Michael Weller, Martin A. M. Reijns, Matthias Preller, Bettina Wiese, Christian Hartmann, and Ruthild G. Weber. Rare adar and rnaseh2b variants and a type i interferon signature in glioma and prostate carcinoma risk and tumorigenesis. Acta Neuropathologica, 134(6):905–922, October 2017. URL: http://dx.doi.org/10.1007/s00401-017-1774-y, doi:10.1007/s00401-017-1774-y. This article has 19 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1007/s00401-017-1774-y)

[3. (Karakoese2024IFNα) Zehra Karakoese, Martha Ingola, Barbara Sitek, Ulf Dittmer, and Kathrin Sutter. Ifnα subtypes in hiv infection and immunity. Viruses, 16(3):364, February 2024. URL: http://dx.doi.org/10.3390/v16030364, doi:10.3390/v16030364. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/v16030364)

[4. (Manry2011Evolutionary) Jérémy Manry, Guillaume Laval, Etienne Patin, Simona Fornarino, Yuval Itan, Matteo Fumagalli, Manuela Sironi, Magali Tichit, Christiane Bouchier, Jean-Laurent Casanova, Luis B. Barreiro, and Lluis Quintana-Murci. Evolutionary genetic dissection of human interferons. Journal of Experimental Medicine, 208(13):2747–2759, December 2011. URL: http://dx.doi.org/10.1084/jem.20111680, doi:10.1084/jem.20111680. This article has 147 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1084/jem.20111680)

[5. (Feng2013Bioinformatics) Di Feng and Betsy J. Barnes. Bioinformatics analysis of the factors controlling type i ifn gene expression in autoimmune disease and virus-induced immunity. Frontiers in Immunology, 2013. URL: http://dx.doi.org/10.3389/fimmu.2013.00291, doi:10.3389/fimmu.2013.00291. This article has 21 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fimmu.2013.00291)

[6. (Chan2006Variation) A Chan, D L Newman, A M Shon, D H Schneider, S Kuldanek, and C Ober. Variation in the type i interferon gene cluster on 9p21 influences susceptibility to asthma and atopy. Genes &amp; Immunity, 7(2):169–178, January 2006. URL: http://dx.doi.org/10.1038/sj.gene.6364287, doi:10.1038/sj.gene.6364287. This article has 16 citations.](https://doi.org/10.1038/sj.gene.6364287)